Effectiveness of Telemedicine Visits in Reducing 30‐Day Readmissions Among Patients With Heart Failure During the COVID‐19 Pandemic
Background The COVID‐19 pandemic resulted in a rapid implementation of telemedicine into clinical practice. This study examined whether early outpatient follow‐up via telemedicine is as effective as in‐person visits for reducing 30‐day readmissions in patients with heart failure. Methods and Results...
Main Authors: | Hanzhang Xu, Bradi B. Granger, Connor D. Drake, Eric D. Peterson, Matthew E. Dupre |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-04-01
|
Series: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
Subjects: | |
Online Access: | https://www.ahajournals.org/doi/10.1161/JAHA.121.023935 |
Similar Items
-
Long‐Term Exposure to Particulate Air Pollution Is Associated With 30‐Day Readmissions and Hospital Visits Among Patients With Heart Failure
by: Cavin K. Ward‐Caviness,, et al.
Published: (2021-05-01) -
Factors associated with racial differences in all-cause 30-day readmission in adults with cardiovascular disease: an observational study of a large healthcare system
by: Hanzhang Xu, et al.
Published: (2022-11-01) -
Heart failure drug classes and 30-day unplanned hospital readmission among patients with heart failure in Ethiopia
by: Birhanu Ayenew, et al.
Published: (2023-11-01) -
Substitution of telemedicine for clinic visit during the COVID‐19 pandemic of 2020: Comparison of telemedicine and clinic visit
by: Yukiko Onishi, et al.
Published: (2022-09-01) -
Clinical Support through Telemedicine in Heart Failure Outpatients during the COVID-19 Pandemic Period: Results of a 12-Months Follow Up
by: Paolo Severino, et al.
Published: (2022-05-01)